BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Beam Therapeutics (BEAM) stock falls as patient dies after receiving the company's gene editing therapy.in an early-stage ...

BEAM-101 is an ex vivo genetic therapy delivered as part of an autologous haematopoietic stem cell transplant (HSCT) after a ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

To accelerate its production, Israel recently invested over USD 500 million in contracts with local defense companies, Rafael ...

Initial Clinical Data for BEAM-101 and Preclinical Non-human Primate Data for ESCAPE Accepted for Presentation at American Society of Hematology ...

Analysts estimate that Beam Therapeutics will report an earnings per share (EPS) of $-1.16. The announcement from Beam Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...

A tornado swept through their neighborhood. Once it passed, they thought the worst of it was over, only to step outside and ...

The company Haiku Houses designed the post-and-beam structure reminiscent of a 16th century Japanese country house.

Israeli officials describe the Iron Beam system as being designed to work in tandem with existing air defense platforms such ...